Less is known about the impact of ALK mutations on the CRC in neuroblastoma, but most available neuroblastoma cell lines that harbor activating ALK mutations, such as Kelly and SY5Y, rely on the adrenergic CRC. Here, ALK is linked to colorectal carcinoma.